Cargando…
Application of metabolomics in osteoporosis research
Osteoporosis (OP) is a systemic disease characterized by bone metabolism imbalance and bone microstructure destruction, which causes serious social and economic burden. At present, the diagnosis and treatment of OP mainly rely on imaging combined with drugs. However, the existing pathogenic mechanis...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702081/ https://www.ncbi.nlm.nih.gov/pubmed/36452325 http://dx.doi.org/10.3389/fendo.2022.993253 |
_version_ | 1784839656348581888 |
---|---|
author | Zhao, Zhenyu Cai, Zhengwei Chen, Aopan Cai, Ming Yang, Kai |
author_facet | Zhao, Zhenyu Cai, Zhengwei Chen, Aopan Cai, Ming Yang, Kai |
author_sort | Zhao, Zhenyu |
collection | PubMed |
description | Osteoporosis (OP) is a systemic disease characterized by bone metabolism imbalance and bone microstructure destruction, which causes serious social and economic burden. At present, the diagnosis and treatment of OP mainly rely on imaging combined with drugs. However, the existing pathogenic mechanisms, diagnosis and treatment strategies for OP are not clear and effective enough, and the disease progression that cannot reflect OP further restricts its effective treatment. The application of metabolomics has facilitated the study of OP, further exploring the mechanism and behavior of bone cells, prevention, and treatment of the disease from various metabolic perspectives, finally realizing the possibility of a holistic approach. In this review, we focus on the application of metabolomics in OP research, especially the newer systematic application of metabolomics and treatment with herbal medicine and their extracts. In addition, the prospects of clinical transformation in related fields are also discussed. The aim of this study is to highlight the use of metabolomics in OP research, especially in exploring the pathogenesis of OP and the therapeutic mechanisms of natural herbal medicine, for the benefit of interdisciplinary researchers including clinicians, biologists, and materials engineers. |
format | Online Article Text |
id | pubmed-9702081 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97020812022-11-29 Application of metabolomics in osteoporosis research Zhao, Zhenyu Cai, Zhengwei Chen, Aopan Cai, Ming Yang, Kai Front Endocrinol (Lausanne) Endocrinology Osteoporosis (OP) is a systemic disease characterized by bone metabolism imbalance and bone microstructure destruction, which causes serious social and economic burden. At present, the diagnosis and treatment of OP mainly rely on imaging combined with drugs. However, the existing pathogenic mechanisms, diagnosis and treatment strategies for OP are not clear and effective enough, and the disease progression that cannot reflect OP further restricts its effective treatment. The application of metabolomics has facilitated the study of OP, further exploring the mechanism and behavior of bone cells, prevention, and treatment of the disease from various metabolic perspectives, finally realizing the possibility of a holistic approach. In this review, we focus on the application of metabolomics in OP research, especially the newer systematic application of metabolomics and treatment with herbal medicine and their extracts. In addition, the prospects of clinical transformation in related fields are also discussed. The aim of this study is to highlight the use of metabolomics in OP research, especially in exploring the pathogenesis of OP and the therapeutic mechanisms of natural herbal medicine, for the benefit of interdisciplinary researchers including clinicians, biologists, and materials engineers. Frontiers Media S.A. 2022-11-14 /pmc/articles/PMC9702081/ /pubmed/36452325 http://dx.doi.org/10.3389/fendo.2022.993253 Text en Copyright © 2022 Zhao, Cai, Chen, Cai and Yang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Zhao, Zhenyu Cai, Zhengwei Chen, Aopan Cai, Ming Yang, Kai Application of metabolomics in osteoporosis research |
title | Application of metabolomics in osteoporosis research |
title_full | Application of metabolomics in osteoporosis research |
title_fullStr | Application of metabolomics in osteoporosis research |
title_full_unstemmed | Application of metabolomics in osteoporosis research |
title_short | Application of metabolomics in osteoporosis research |
title_sort | application of metabolomics in osteoporosis research |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702081/ https://www.ncbi.nlm.nih.gov/pubmed/36452325 http://dx.doi.org/10.3389/fendo.2022.993253 |
work_keys_str_mv | AT zhaozhenyu applicationofmetabolomicsinosteoporosisresearch AT caizhengwei applicationofmetabolomicsinosteoporosisresearch AT chenaopan applicationofmetabolomicsinosteoporosisresearch AT caiming applicationofmetabolomicsinosteoporosisresearch AT yangkai applicationofmetabolomicsinosteoporosisresearch |